folfox6
Folfox6 is a drug used to treat Rectal Cancer, Cancer of Colon, Colon Carcinoma, and other conditions. Folfox6 is being actively studied in 1 study and prior, has been studied in 4.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| Barbara Ann Karmanos Cancer Institute | AZ Groeninge Kortrijk - Campus Kennedylaan | Anthony F. Shields, MD PhD |
| European Organisation for Research and Treatment of Cancer - EORTC | AZ Turnhout - Campus Sint Elisabeth | Chang Jian Hua |
| Fudan University | Allgemeines Krankenhaus der Stadt Wien | Gazala Khan, MD |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
B
Completed
- Colorectal Cancer
- +7 more
- FOLFOX6
- EGFRBi armed ATC Infusions
- Detroit, MichiganBarbara Ann Karmanos Cancer Institute
2022-03-30
Mar 30, 2022S
Active, not recruiting
- Rectal Cancer
- Endo-HDR (if randomized to this arm)
- +4 more
- Tampa, Florida
- +3 more
2021-11-01
Nov 1, 2021W
Completed
- Colon Cancer
- Rectal Cancer
- FOLFOX6
- +2 more
- Pawtucket, Rhode Island
- +2 more
2020-05-28
May 28, 2020S
Completed
- Rectal Cancer
- Radiation
- +3 more
- Fort Myers, Florida
- +10 more
2016-12-13
Dec 13, 2016H
Unknown status
- Pancreas Neoplasm Malignant Resectable
- Folfox6
- +3 more
- Detroit, MichiganHenry Ford Health System
2016-10-13
Oct 13, 2016E
Terminated
- Colorectal Cancer Metastatic
- +2 more
- FOLFOX6
- +3 more
- Vienna, Austria
- +24 more
2016-10-11
Oct 11, 2016F
Completed
- Esophageal Squamous Cell Carcinoma
- FOLFOX6
- (no location specified)
2012-05-23
May 23, 2012